# Advanced AI – Requirements Package: MSL Intelligence & Integration Suite
**Date:** 2026-09-14  
**Author:** PM Assistant (Senior Product Manager, Health Tech AI)  
**Based on:** Market Analysis 2026-09-14  
**Feature Domain:** Third-Party Integrations & MSL Products

---

## Feature Opportunity: Compliance-Native MSL Intelligence Suite with Certified Integration Catalog

### Why This Opportunity Now

The market analysis identifies a convergence of three forces creating a narrow but high-value window:

1. **CRM migration wave (2026–2029):** The forced migration from Veeva CRM to Salesforce Life Sciences Cloud is disrupting every incumbent integration in medical affairs. Platforms that provide certified, pre-built connectors for both systems during this transition will capture long-term enterprise contracts.

2. **Compliance as product (not process):** The EU AI Act's high-risk provisions (effective August 2026) and FDA AI guidance finalized in 2026 mean compliance infrastructure is now a procurement requirement, not a nice-to-have. No mid-market MSL AI SaaS currently ships with audit trails, AE detection, and RAG-over-approved-library as first-class features.

3. **MSL role evolution:** Early adopters report 20–35% reductions in MSL admin workload from AI agent integration. The value is real, but most solutions require significant IT integration work, placing them out of reach for non-top-10 pharma.

ADVANCE AI's dual mandate—third-party integrations and MSL products—maps directly to the gap: a compliance-native platform that connects to existing CRM and EHR infrastructure while automating MSL workflows, available to mid-market pharma without a multi-year IT program.

---

## User Stories

### Story 1: Pre-Call Intelligence Brief
**As an** MSL preparing for a KOL engagement,  
**I want** an auto-generated, compliance-reviewed pre-call brief that surfaces the HCP's recent publications, relevant clinical trial activity, and approved scientific talking points from my company's content library,  
**so that** I can walk into every scientific exchange fully prepared without spending 2–3 hours on manual research and document assembly.

#### Acceptance Criteria

**Given** an MSL selects an upcoming HCP meeting in the CRM (Veeva Vault or Salesforce Life Sciences Cloud),  
**When** they click "Generate Pre-Call Brief,"  
**Then** the system retrieves the HCP's last 12 months of published literature, any open clinical trial affiliations, and approved on-label scientific content from the company's medical content library, assembles a structured 1-page brief, flags any off-label references for medical review, and delivers the brief within 90 seconds.

**Given** the brief is generated,  
**When** any content is sourced from an external database (PubMed, ClinicalTrials.gov),  
**Then** each claim is linked to its source with a retrievable citation, and the audit log records the retrieval timestamp, source, and content version for regulatory review.

**Given** the MSL edits or annotates the brief,  
**When** they save changes,  
**Then** the edited version is versioned, the original AI-generated version is preserved in the audit log, and the delta is flagged for optional medical affairs review before field use.

---

### Story 2: Field Insight Capture and Routing
**As a** Medical Affairs manager responsible for synthesizing field intelligence,  
**I want** MSL field insights captured in a structured, searchable format and automatically routed to the relevant cross-functional teams (HEOR, Medical Information, Commercial),  
**so that** the intelligence gathered from HCP interactions drives downstream decisions rather than sitting in unread call notes.

#### Acceptance Criteria

**Given** an MSL completes a field visit and opens the insight capture form in the ADVANCE AI app (or CRM integration),  
**When** they submit their post-call notes (structured or free-text),  
**Then** the system extracts key insight categories (unmet medical need, competitor mention, safety signal, publication request, data gap) using NLP, maps each insight to a predefined taxonomy, and routes it to the appropriate team queue within 5 minutes.

**Given** a safety signal keyword is detected in the captured insight,  
**When** the system classifies the input,  
**Then** it immediately flags the record as a potential adverse event, triggers the company's AE reporting workflow, and notifies the medical safety team—without requiring the MSL to take any additional action.

**Given** insights are routed to a cross-functional team,  
**When** a team member views the insight dashboard,  
**Then** they can filter by therapeutic area, insight type, geography, and date range, and export a de-identified summary report compatible with the company's existing BI tools (Tableau, Power BI, Veeva Vault reports).

---

### Story 3: Certified CRM Integration Setup
**As a** pharmaceutical IT administrator onboarding ADVANCE AI,  
**I want** a guided, documented integration setup process for both Veeva Vault and Salesforce Life Sciences Cloud,  
**so that** our MSL team can use ADVANCE AI features within their existing CRM workflow within 2 weeks without a custom development engagement.

#### Acceptance Criteria

**Given** an IT administrator starts a new ADVANCE AI workspace,  
**When** they select "Configure CRM Integration" and choose Veeva Vault or Salesforce Life Sciences Cloud,  
**Then** the system presents a step-by-step OAuth-based connection wizard, validates API permissions, and confirms a successful bi-directional sync (HCP records, meeting activity, call notes) within a single 2-hour setup session.

**Given** the CRM integration is active,  
**When** an MSL logs a call in the CRM,  
**Then** the ADVANCE AI insight capture form auto-populates with HCP context (name, affiliation, recent interactions) and the completed insight record syncs back to the CRM as a structured activity record within 60 seconds.

**Given** a CRM field mapping conflict exists (e.g., custom Veeva fields not in Salesforce),  
**When** the system detects the conflict during setup,  
**Then** it presents a visual field-mapping interface where the administrator can resolve conflicts without writing code, and the resolution is documented in a configuration audit log.

---

### Story 4: Compliance Dashboard for Medical Affairs Leadership
**As a** Head of Medical Affairs responsible for regulatory compliance,  
**I want** a real-time dashboard showing AI usage, content sourcing, and audit trail completeness across all MSL AI interactions,  
**so that** I can demonstrate EU AI Act and FDA AI guidance conformance to regulators and internal compliance teams without manual reporting.

#### Acceptance Criteria

**Given** the compliance dashboard is accessed by an authorized medical affairs leader,  
**When** they view the dashboard,  
**Then** it displays: total AI-generated content volume (last 30/90/365 days), percentage of outputs reviewed by a human before field use, AE flags triggered and resolved, content library coverage vs. external source usage, and any overrides of AI recommendations—updated in real time.

**Given** a regulatory audit request is received,  
**When** the compliance officer exports an audit package for a specified date range,  
**Then** the system generates a structured PDF/JSON report containing complete interaction logs, AI model version used, content retrieval sources, human review records, and AE flag disposition—meeting EU AI Act Article 13 transparency requirements.

**Given** a new AI model version is deployed,  
**When** the update is applied to the production environment,  
**Then** the system logs the version change with a timestamp, records the validation test results, and all subsequent interactions are tagged with the new model version in the audit trail.

---

### Story 5: Literature Monitoring with Automated Briefing
**As an** MSL covering a specific therapeutic area,  
**I want** automated weekly alerts summarizing newly published literature relevant to my HCP portfolio and assigned indications,  
**so that** I stay current on the scientific landscape without manually searching PubMed, NEJM, and congress abstracts every week.

#### Acceptance Criteria

**Given** an MSL has configured their therapeutic area and HCP portfolio in ADVANCE AI,  
**When** new literature matching their configured keywords and authors is published (PubMed, key journals, major congress abstract databases),  
**Then** the system delivers a structured weekly digest (email and in-app) summarizing each paper: key finding, relevance to their indication, relevant HCPs in their territory who are authors or cited, and an approved-content alignment note if applicable—within 24 hours of publication indexing.

**Given** a literature alert contains a paper authored by an MSL's key HCP,  
**When** the MSL views the alert,  
**Then** the system recommends a follow-up engagement action (e.g., "Schedule scientific exchange re: [paper title]"), pre-populates a meeting request draft in the CRM, and links the paper as context for the pre-call brief generator.

**Given** the MSL marks a paper as "not relevant,"  
**When** they dismiss the alert,  
**Then** the system updates the personalization model to reduce similar content in future alerts, and the dismissal is logged (but does not affect the audit trail for compliance purposes).

---

## One-Page Product Spec: MSL Intelligence Suite with Integration Catalog

### Problem Statement

Medical Science Liaisons spend 40–80% of their work time on travel and administrative tasks (manual CRM updates, literature searches, call report writing, insight documentation). When MSLs do generate valuable field insights, those insights are captured in unstructured call notes that rarely reach the cross-functional teams who need them. Meanwhile, pharmaceutical IT teams face a 2026–2029 CRM migration from Veeva to Salesforce Life Sciences Cloud with no clear guidance on which AI tools will work across both systems. The result: MSLs are underutilized as scientific intelligence assets, insights evaporate at the field level, and AI platform evaluations stall waiting for integration certainty.

Compliance compounds the problem. The EU AI Act (high-risk provisions: August 2026) and finalized FDA AI guidance now require pharmaceutical companies to maintain audit trails, human review records, and content sourcing documentation for any AI used in regulated workflows. No mid-market pharma AI SaaS currently ships with these capabilities as native product features.

### Proposed Solution

**ADVANCE AI MSL Intelligence Suite** — a compliance-native SaaS platform that reduces MSL administrative burden by 30%, structures and routes field insights to cross-functional teams, and connects to existing CRM and EHR infrastructure through a certified integration catalog—deployable in 2 weeks without a custom development engagement.

**Core Modules (Phase 1):**
- **Pre-Call Brief Generator:** RAG-powered, sourced from approved medical content library + external literature databases; fully auditable
- **Insight Capture & Routing:** Structured NLP extraction, automatic AE flag detection, cross-functional routing with BI tool export
- **Certified Integration Catalog:** Pre-built, OAuth-based connectors for Veeva Vault, Salesforce Life Sciences Cloud, and Epic (Phase 1); Cerner, Medidata in Phase 2
- **Compliance Dashboard:** Real-time audit trail visibility, EU AI Act Article 13 reporting export, model version tracking

**Phase 2 (next 6 months):**
- Literature monitoring with automated weekly digests
- KOL engagement scoring and prioritization
- Multi-modal insight capture (voice-to-structured-text from field calls)

### Success Metrics

| Metric | Target | Measurement Method |
|---|---|---|
| MSL admin time reduction | ≥25% within 90 days of deployment | Time-tracking survey (pre/post) + CRM activity log delta |
| Pre-call brief adoption rate | ≥70% of scheduled HCP meetings | Platform usage analytics |
| Insight routing accuracy | ≥90% correct team routing (no manual re-routing) | Routing correction audit (sample 10% of routed insights) |
| CRM integration setup time | ≤2 business days for standard Veeva or Salesforce setup | IT onboarding log timestamps |
| Compliance dashboard audit export success | 100% (no failed exports on audit request) | Export success rate tracking |
| AE flag false positive rate | ≤15% | Safety team review of flagged records vs. confirmed AEs |
| Time to first value (new customer) | ≤14 calendar days from contract to live MSL usage | Customer success milestone tracking |

### Out of Scope (Phase 1)

- Drug discovery or clinical trial management workflows
- Promotional content creation or medical communications authoring
- Direct patient engagement or consumer-facing features
- Payer contracting or formulary management (MMIT use case)
- Custom AI model training on customer-specific datasets (available Phase 3+)
- HIPAA-regulated patient data processing (PHI-free design constraint for Phase 1)
- Integration with non-US regulatory submissions systems (EU, PMDA Phase 2+)
